Abstract

In this study, a biocompatible chitosan/montmorillonite (CS/MMT) composite microsphere was developed as a carrier for loading and sustained-release of the hydrophobic drug of tanshinone IIA. Though the compatibility between hydrophobic drugs and hydrophilic matrix was fairly poor, tanshinone IIA was successfully loaded on the microsphere by the solvent exchange process during chitosan matrix dehydration. The microstructure of the resulting microspheres was characterized with several techniques, such as X-ray diffraction (XRD), thermo-gravimetric analysis (TGA), Fourier transform infrared spectroscopy (FT-IR), and scanning electron microscope (SEM). The results of drug loading and in vitro release study of the tanshinone IIA loaded CS/MMT composite microspheres showed that the incorporation of MMT into CS matrix would enhance the drug encapsulation and retard drug migration. The sample with mass ratio of CS: MMT (10:2) exhibited highest encapsulation efficiency (48.18% ± 2.54%) and slowest continuous cumulative release of drug in phosphate buffer solution (pH 7.4). It was found that the tanshinone IIA release kinetics fit the Higuchi model and the release mechanism was non-Fickian diffusion. Cell viability studies by CCK-8 assay showed that the microspheres showed no obvious cytotoxicity at the dosages below 80 μg/ml, and the MMT content had no significant effect on cell viability. This work provided a successful method of incorporating hydrophobic drugs into hydrophilic matrices, and has been successfully applied to the preparation of effective and biocompatible drug delivery for tanshinone IIA.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.